Transcutaneous Pacing Guidelines

Indications and Recommendations

The American College of Cardiology recommends transcutaneous pacing as the first-line temporary pacing modality for symptomatic bradycardia unresponsive to medical therapy, particularly in emergency situations where immediate intervention is needed before more definitive therapy can be instituted 1, 2
Hemodynamically unstable patients with symptomatic bradycardia unresponsive to medical therapy should receive transcutaneous pacing, as recommended by the American College of Cardiology 3, 4
The American College of Cardiology also recommends transcutaneous pacing for ventricular asystole 3, 5
Patients requiring temporary pacing while awaiting transvenous pacing or permanent pacemaker placement should be considered for transcutaneous pacing, according to the American Heart Association 2, 6

Higher current may be required in patients with emphysema, as noted by the American College of Cardiology 5
Patients with pericardial effusion may require higher current for transcutaneous pacing, as recommended by the American Heart Association 2
Mechanical capture must be confirmed by assessing arterial pulse or waveform, and alternative ECG leads should be considered if pacing artifact obscures QRS complex, as suggested by the American Heart Association 2, 6
Additional monitoring methods, such as arterial pressure and pulse oximetry, should be used when ECG assessment is difficult, as recommended by the American Heart Association 6, 7
Transcutaneous pacing is associated with significant discomfort, and adequate sedation and analgesia should be provided for conscious patients, as noted by the American Heart Association 2, 6
Continuous cardiac monitoring is necessary until pacing is no longer required, as recommended by the American Heart Association 2, 6

Transcutaneous pacing should be considered a bridge to more definitive therapy, as recommended by the American College of Cardiology 8, 4
For patients likely to require prolonged pacing, transition to transvenous or permanent pacing is recommended, according to the American College of Cardiology 8, 9
Transcutaneous pacing is particularly valuable in patients receiving thrombolytic therapy, reducing the need for vascular interventions, as noted by the American College of Cardiology 8, 3
Significant patient discomfort and variable capture reliability are limitations of transcutaneous pacing, as noted by the American Heart Association 2, 6
Difficulty confirming mechanical capture due to large pacing artifact is a complication of transcutaneous pacing, as reported by the American Heart Association 6, 7

Transcutaneous pacing delivers electrical impulses through the skin that can potentially conduct to anyone in contact with the patient, creating a risk of electrical shock to providers in direct contact with the patient during active pacing 10
The American Heart Association recommends using arterial pressure monitoring to confirm mechanical capture, employing pulse oximetry to verify perfusion and capture, and utilizing different ECG monitoring leads to minimize pacing artifact and maximize QRS visualization 10

The American Heart Association recommends confirming effective capture through noninvasive or invasive means rather than direct palpation 11
If assessment is still needed, temporarily pause pacing if clinically appropriate to assess native rhythm and pulse, and resume pacing immediately if the patient remains symptomatic 12

Transcutaneous pacing produces large artifacts that can obscure ECG interpretation 10

The American Heart Association advises against attempting to manually palpate pulses during active pacing and relying solely on ECG evidence of capture without confirming mechanical capture 10
Failing to use alternative monitoring methods when ECG assessment is difficult is also a common pitfall to avoid 10

The American Heart Association recommends transcutaneous pacing (TCP) as a bridge to more definitive therapy for patients with symptomatic bradycardia who do not respond to atropine, with pacing not being effective for asystolic cardiac arrest and may delay or interrupt chest compressions 13